Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference
January 05 2023 - 8:00AM
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
innovative life sciences technology company providing mission
critical automation solutions to facilitate the efficient
manufacturing and fast, safe release of healthcare products, today
announced that the Company will present at the 41st Annual J.P.
Morgan Healthcare Conference.
The Company is scheduled to present on Thursday,
January 12, 2023 at 9:45am Pacific Time (12:45pm Eastern Time). A
live webcast of the presentation will be available on the Rapid
Micro Biosystems investor relations website at
https://investors.rapidmicrobio.com/ and can be accessed here. The
webcast will be archived and available for replay for at least 30
days after the event.
About Rapid Micro
Biosystems
Rapid Micro Biosystems is an innovative life
sciences technology company providing mission critical automation
solutions to facilitate the efficient manufacturing and fast, safe
release of healthcare products such as biologics, vaccines, cell
and gene therapies, and sterile injectables. The Company’s flagship
Growth Direct system automates and modernizes the antiquated,
manual microbial quality control (“MQC”) testing workflows used in
the largest and most complex pharmaceutical manufacturing
operations across the globe. The Growth Direct system brings the
quality control lab to the manufacturing floor, unlocking the power
of in-line/at-the-line MQC automation to deliver faster results,
greater accuracy, increased operational efficiency, better
compliance with data integrity regulations, and quicker decision
making, that customers rely on to ensure safe and consistent supply
of important healthcare products. The Company is headquartered and
has U.S. manufacturing in Lowell, Massachusetts, with global
locations in Lexington, Massachusetts, Switzerland, Germany, and
the Netherlands.
For more information, please
visit www.rapidmicrobio.com or follow the Company on
Twitter at @rapidmicrobio or on LinkedIn.
Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
mbeaulieu@rapidmicrobio.com
Media Contact:
media@rapidmicrobio.com
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Jul 2024 to Aug 2024
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Aug 2023 to Aug 2024